EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful Treatment of an Advanced Larynx Carcinoma Using Neo-Adjuvant Chemo-Immunotherapy and Cisplatin/Radiotherapy for a Patient with Rendu–Osler Disease

Bruno Chauffert, Tamim Alsuliman, Hanene Oueslati, Abdenour Ouikene, Farid Belkhir, Sana Nemmaoui, Alexandre Cau, Agnes Galez, Thomas Garnier, Valéry Salle, Reda Garidi

Journal of Clinical Medicine · 12.08.2025 · 14 (16) · 5694

DOI: 10.3390/jcm14165694 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.08.2025. Verfasst von Bruno Chauffert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Rendu–Osler disease is a rare genetic disease, characterized by widespread telangiectasia that can involve the skin and mucous membranes. The diagnosis is based on spontaneous and recurrent epistaxis; various mucosal and cutaneous telangiectasia at typical sites; visceral manifestations including gastrointestinal telangiectasia or pulmonary, cerebral, or hepatic arteriovenous malformation; and a first-degree relative with hereditary hemorrhagic telangiectasia. Squamous cell carcinoma of the larynx generally develops in patients with a smoking history. It is most often treated by surgery and/or radiotherapy. To our knowledge, these two entities were never reported in the same patient.

Methods

We herein report a case of a 51-year-old man with Rendu–Osler disease. He was subsequently diagnosed with a locally advanced well-differentiated squamous cell carcinoma of the vocal cord.

Results

The patient received a neo-adjuvant chemo-immunotherapy, with nine weekly injections of paclitaxel (60 mg/m2/week), cisplatin (30 mg/m2/week), and cetuximab (250 mg/m2/week), and three injections of pembrolizumab (200 mg every 3 weeks). This controlled tumor bleeding, and then cisplatin-enhanced radiotherapy helped obtain a complete remission.

Conclusions

Locally advanced squamous cell carcinoma of the larynx treatment in the context of active Rendu–Osler disease is challenging. If the wide curative surgical approach is deemed too risky, neo-adjuvant chemo-immunotherapy may present a helpful alternative as it may enhance the conditions in order to perform classical radiotherapy with concomitant cisplatin.

Schlagwörter

Stichwörter der Autor:innen

Rendu–Osler diseasecetuximabchemo-immunotherapycisplatincisplatin-enhanced radiotherapypaclitaxelpembrolizumabsquamous cell carcinoma of larynx

Autor:innen und Institutionen

  • Department of Oncology-Hematology, Centre Hospitalier de Saint-Quentin, 1 Av. Michel de l'Hospital BP 608, 02321 Saint-Quentin, France.
  • Department of Radiotherapy, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
  • Department of Pharmacy, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
  • Department of Oto-Rhino-Laryngology, Centre Hospitalier de Saint-Quentin, 02321 Saint-Quentin, France.
  • Department of Internal Medicine, CHU Amiens-Picardie, 1 Place Victor Pauchet, 80054 Amiens, France.

Zitieren

APA

Chauffert, B., Alsuliman, T., Oueslati, H., Ouikene, A., Belkhir, F., Nemmaoui, S., Cau, A., Galez, A., Garnier, T., Salle, V., & Garidi, R. (2025). Successful Treatment of an Advanced Larynx Carcinoma Using Neo-Adjuvant Chemo-Immunotherapy and Cisplatin/Radiotherapy for a Patient with Rendu–Osler Disease. Journal of Clinical Medicine, 14(16), 5694. https://doi.org/10.3390/jcm14165694

Vancouver

Chauffert B, Alsuliman T, Oueslati H, Ouikene A, Belkhir F, Nemmaoui S, et al. Successful Treatment of an Advanced Larynx Carcinoma Using Neo-Adjuvant Chemo-Immunotherapy and Cisplatin/Radiotherapy for a Patient with Rendu–Osler Disease. Journal of Clinical Medicine. 2025;14(16):5694. doi:10.3390/jcm14165694

BibTeX
@article{Chauffert2025,
  author = {Chauffert, Bruno and Alsuliman, Tamim and Oueslati, Hanene and Ouikene, Abdenour and Belkhir, Farid and Nemmaoui, Sana and Cau, Alexandre and Galez, Agnes and Garnier, Thomas and Salle, Valéry and Garidi, Reda},
  title = {Successful Treatment of an Advanced Larynx Carcinoma Using Neo-Adjuvant Chemo-Immunotherapy and Cisplatin/Radiotherapy for a Patient with Rendu–Osler Disease},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {16},
  pages = {5694},
  doi = {10.3390/jcm14165694}
}
Kostenlos starten →